Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vext Science Inc. C.VEXT

Alternate Symbol(s):  VEXTF | C.VEXT.W | C.VEXT.W.A

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Vext Science Inc. through its subsidiaries operates as agricultural technology, services, and property management company in Canada. It... see more


Bullboard (CSE:VEXT)

View:
1 2 3 4 5 6 7 8 9 10 11 Next
Post by lscfaon Mar 23, 2023 1:22pm

Huge upside to cannabis stock Vext Science, says Beacon

https://www.cantechletter.com/2023/03/huge-upside-to-cannabis-stock-vext-science-says-beacon/#
104
User Avatar Image
(4)
•••
  • apainterX
Comment by apainteron Mar 22, 2023 3:06pm

RE:p/e = 2.2x

Thanks IsScfa, nice find, I will look into this and join you  Really appreciate your postings
29

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

posted Jun 06, 2023 9:00am  by  Numinus Wellness Inc.
"We're excited to support MindMed in their clinical trial work, by evaluating new important treatments and protocols to address mental health disorders...The fact that our Draper research clinic is the top enrolling site for the study underscores the quality of our clinical research capabilities and recruiting efforts ...read more
Post by lscfaon Mar 22, 2023 11:35am

p/e = 2.2x

eps = $0.08 US = $0.11 cad
68
Post by lscfaon Dec 21, 2022 6:40pm

Vext Science is a Buy, says Beacon

https://www.cantechletter.com/2022/12/vext-science-is-a-buy-says-beacon/
152
Post by lscfaon Dec 21, 2022 6:40pm

Huge upside to Vext Science, says Echelon

https://www.cantechletter.com/2022/12/huge-upside-to-vext-science-says-echelon/
127
Post by lscfaon Dec 19, 2022 11:45am

Vext Science is a triple, says Haywood

https://www.cantechletter.com/2022/12/vext-science-is-a-triple-says-haywood/
123
User Avatar Image
(1)
•••
  • kingtrollerX
Post by kingtrolleron Nov 21, 2022 10:16am

Q3 2022

https://stockhouse.com/news/press-releases/2022/11/17/vext-announces-q3-2022-financial-results-us-7-7-million-revenue-solid-60-gross
218
Post by lscfaon Nov 15, 2022 1:20pm

Beacon $2.25 target

https://www.cantechletter.com/2022/11/vext-science-is-looking-very-attractive-says-beacon/#
141

Thematica Insights Report and Investor Guide

Beyond Precious

An investor's guide to precious metals and their potential in today's market. Click here to access the report.
Jocelyn Aspa
6 June 2023 09:00
Post by lscfaon Nov 07, 2022 2:28pm

Echelon reiterates $1.75 target price

https://www.cantechletter.com/2022/11/vext-science-is-a-buy-in-us-cannabis-says-echelon/#
112
User Avatar Image
(1)
•••
  • kingtrollerX
Post by kingtrolleron Nov 04, 2022 11:55am

Building in Ohio

https://stockhouse.com/news/press-releases/2022/11/03/vext-science-announces-approval-to-begin-building-out-ohio-facility-to-support
44
Post by lscfaon Aug 30, 2022 8:29am

Undervalued

Forward ebitda $20 mil / 177 million diluted shs = $0.113/sh.      P/ebitda = $0.38/$0.113 = 3.4x
153
Post by retiredcfon Aug 26, 2022 8:39am

Canaccord

Vext Science Inc  Canaccord Genuity cuts target price to C$1.30 from C$1.60
87
User Avatar Image
(680)
•••
  • Dunworkin2X
Post by Dunworkin2on Aug 15, 2022 2:51pm

New director Opzoomer

Has started building a nice position with steady public market buys.
88
Post by lscfaon Jul 14, 2022 11:40pm

Echelon target $1.75

https://www.cantechletter.com/2022/07/buy-vext-science-in-us-cannabis-says-echelon-capital/#
155
User Avatar Image
(223)
•••
  • TrevorAbesX
Post by TrevorAbeson Jul 08, 2022 5:28pm

VEXT secures US$22.2M credit facility

https://themarketherald.ca/vext-science-csevext-secures-us22-2m-credit-facility-2022-07-08/
108
1 2 3 4 5 6 7 8 9 10 11 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >